Abstract Background Vasoplegic syndrome is associated with high mortality. Methylene blue (MB) is a guanylate cyclase inhibitor that ameliorates this re-distributive type of shock. This study aims to investigate the..
Read MoreAbstract Objectives To summarize the evidence of the hemodynamic effects and vasopressor requirements of adult cardiac surgery patients with vasoplegic shock treated with hydroxocobalamin or methylene blue. Design Systematic review..
Read MoreAbstract A dysregulated host response is a common feature in critically ill patients due to both infectious and non-infectious origins that can lead to life-threatening organ dysfunction, which is still..
Read MoreAbstract A dysregulated host response is a common feature in critically ill patients due to both infectious and non-infectious origins that can lead to life-threatening organ dysfunction, which is still..
Read MoreAbstract Objectives To compare changes in vasopressor requirements and hemodynamic responses after hydroxocobalamin or methylene blue administration for vasoplegic shock (VS). Design Retrospective cohort analysis. Setting Single-center, academic medical center...
Read MoreAbstract Objectives Approximately 8 - 10 % of COVID-19 patients present with a serious clinical course and need for hospitalization, 8% of hospitalized patients need ICU-treatment. Currently, no causal therapy..
Read MoreAbstract Objective The treatment of refractory vasodilatory shock in patients undergoing (ECMO) is an area in which there is minimal literature. Based on previous literature, the authors hypothesized that at least..
Read MoreAbstract Hemodynamic conditions with reduced commonly are observed in patients undergoing cardiac surgery and may range from moderate reductions in , as a side effect of general anesthetics, to a profound vasodilatory..
Read MoreTHE CURRENT pandemic owing to coronavirus disease 2019 (COVID-19) has been associated in about 10% to 15% of cases with severe clinical presentations that require admission to hospital. In the..
Read MoreIn these patients there is a high chance of success (shock reversal) possibly translating to survival benefits when the adsorber treatment is started in good time. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/CytoSorb-Therapy_compressed.pdf" title="CytoSorb..
Read More








